Hyperliquid Strategies, Inc. (PURR)
10.36
-0.61
(-5.56%)
USD |
NASDAQ |
Jun 03, 16:00
10.54
+0.18
(+1.74%)
After-Hours: 19:59
Hyperliquid Strategies EPS Diluted (Quarterly) : 1.011 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 152.51M |
| Revenue (Quarterly) | 2.626M |
| Total Expenses (Quarterly) | -149.88M |
| Enterprise Value | 1.472B |
| Earnings Yield | -14.02% |